Emergent BioSolutions Inc.
Net SellingEBS·US·🇺🇸 US
0%buys·100%sales
3,403 transactions$503KTotal buys·8 buys
$220.9MTotal sells·1,902 sells
4545 insiders
Last: Apr 1, 2026
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 1, 26 | Williams Paul Anthony | Sell | $34K | |
| Dec 14, 25 | Lowry Simon C | Other | $40K | |
| Dec 5, 25 | Richard Ronald | Exercise | - | |
| Dec 5, 25 | Richard Ronald | Sell | $86K | |
| Dec 5, 25 | Richard Ronald | Exercise | $129K | |
| Dec 5, 25 | Richard Ronald | Other | $129K | |
| Dec 5, 25 | Richard Ronald | Sell | $177K | |
| Nov 11, 25 | Hartzel William | Other | $7K | |
| Nov 10, 25 | DeGolyer Donald W | Sell | $188K | |
| Nov 7, 25 | Dayal Sujata Tyagi | Sell | $86K |
Emergent BioSolutions Inc. (EBS) has recorded 3 403 insider transactions from 45 insiders. Total insider buying volume stands at $503K, while total selling volume is $220.9M. Overall insider sentiment is bearish (100% sales).
Emergent BioSolutions Inc. (EBS) has recorded 3 403 insider operations, including 8 open-market purchases ($503K), 1 902 sales ($220.9M) and 1 493 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bearish (100% sales).
Insider activity at Emergent BioSolutions Inc. is sustained, with operations recorded in 9 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are El-Hibri Fuad (CEO), PAPA JOSEPH C (CEO) & Abdun-Nabi Daniel (CEO), with respectively 530, 326, 261 transactions.
Across all 3 403 recorded transactions, the breakdown by type is: sales (1902, 56%), exercise (632, 19%), grant (492, 14%), tax (248, 7%), other (103, 3%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Emergent BioSolutions Inc. has recorded 3 403 insider operations in total, including 8 open-market purchases ($503K), 1 902 sales ($220.9M) and 1 493 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 1, 2026.
Insiders at Emergent BioSolutions Inc. are currently net sellers, with 0% purchases and 100% sales across all reported transactions. Total buy volume is $503K versus $220.9M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 45 insiders at Emergent BioSolutions Inc. (EBS). El-Hibri Fuad (CEO, 530 tx), PAPA JOSEPH C (CEO, 326 tx), Abdun-Nabi Daniel (CEO, 261 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for EBS is bearish, based on a 0% buy ratio across 1 910 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Emergent BioSolutions Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.